Cyclosporine for Dry Eye Associated With Nivolumab
Alexander T. Nguyen(Yale New Haven Health System), Jessica Chow(Wested), Mario Sznol(Yale University), Miguel A. Materin(Wested), Maxwell Elia(Wested)
Cited by 65
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2015|1.2k
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753